Abstract:Graphical abstract of the study on cutaneous squamous cell carcinoma in situ, commonly known as Bowen's disease, with the primary objective of comparing the efficacies of different treatment interventions. The top right corner section depicts the methods used herein: the study begins with a systematic literature search to identify relevant studies. Subsequently, a quality assessment of the studies is conducted. Data extraction focuses on several key metrics: lesion clearance ates (LCR), participant clearance rates (PCR), lesion recurrence rates (LRR), participant recurrence rates (PRR) and baseline characteristics. The extracted data are then used to group the various interventions, including PDT, 5% 5‐FU, cryotherapy and surgery, among others. Two meta‐analyses of proportions are conducted for each outcome using a generalized linear mixed model: one focusing exclusively on high‐quality studies, and another encompassing all study arms to ensure comprehensive results. At the bottom left, the meta‐analysis process using forest plots is illustrated. The treatment efficacies are presented in descending order in treatment rankings, exemplified with a ranking of LCR. At the bottom right, the conclusions are stated: the efficacy comparison provides a thorough overview of the efficacy outcomes for practice‐relevant interventions in treating Bowen's disease. Additionally, the study addresses the challenges in comparability, highlighting the variability in treatment rankings across LCR, PCR, LRR and PRR. It also discusses the limitations in comparability due to the different numbers of studies between treatment groups and outcome measures, as well as methodical and clinical heterogeneity. Background Cutaneous squamous cell carcinoma in situ (Bowen's disease) is a precancerous condition confined to the epidermis of the skin. Despite the critical need for effective interventions to halt its progression, there remains a notable shortage of comprehensive data comparing the efficacy of various therapeutic approaches. Objectives This systematic review and meta‐analysis endeavour to compare the different efficacies of interventions by investigating and synthesizing data from numerous trials. Methods A pre‐defined protocol was registered in PROSPERO (CRD42021242224, registration date: 16 April 2021). Systematic searches in Medline, Embase and Central, along with manual trial register searches, identified studies reporting lesion clearance rates (LCR), participant clearance rates (PCR) or recurrence rates (date of last search: 12 June 2024). Quality assessment followed guidelines from the National Heart, Lung, and Blood Institute (NHLBI). After the study arms were categorized into treatment groups and groups of study quality, the proportions were pooled using the generalized linear mixed model (GLMM) as meta‐analytical method. Results A comprehensive inclusion of 71 studies facilitated an evaluation of 3783 lesions for LCR, 1225 patients for PCR, 4073 lesions for lesion recurrence rates (LRR) and 740 patients for participant recurrence rates (PRR). Surgery demonstrated the highest LCR and PCR (0.97, 95% confidence interval (CI): 0.90–0.99) and the lowest LRR (0.04, 95% CI: 0.02–0.07). Conclusions This study provides a thorough overview of reported efficacy outcomes for practice‐relevant interventions for Bowen's disease. Surgery outperformed other treatments for Bowen's disease. For the other intervention groups, it was not possible to show clear differences in effectiveness: LCR, PCR, LRR and PRR showed various treatment rankings, and the comparability was restricted by different numbers of studies between treatment groups and outcome measures, methodical and clinical heterogeneity. Further high‐quality studies are needed to investigate practice‐relevant interventions for Bowen's disease.

Multiple Bowen's disease due to long‐term narrow‐band ultraviolet B phototherapy: A case report and literature review

Multiple Bowen Disease Lesions With the "Eyeliner Sign" in a Psoriasis Patient After Long-Term Narrow-Band Ultraviolet B Light Therapy

Clinical and histopathological characteristics, diagnosis and treatment, and comorbidities of Bowen's disease: a retrospective study

Clinical and histopathological characteristics, diagnosis and treatment, and comorbidities of Bowen’s disease: a retrospective study

Narrow-band Ultraviolet B and Conventional UVB Phototherapy in Psoriasis: a Randomised Controlled Trial

Oral Acitretin Combined with Surgical Excision for the Treatment of Multiple Bowen's Disease and Squamous Cell Carcinoma: a Case Report

Evaluation of Biological Effects and Transcriptome Changes Induced by LED-Based Narrow-Band UVB Phototherapy

Carcinogenic effects of prolonged daily low-emission phototherapy in psoriasis

Effect of Traditional Chinese Medicine plus narrow-band medium-wave ultraviolet B radiation on moderate-to-severe psoriasis vulgaris in a case series

A Case of Bowenoid Papulosis Treated with Sequential Curettage and Photodynamic Therapy

Narrowband Ultraviolet B Phototherapy for Generalized Granuloma Annulare: Real-Life Experience and Review of the Literature

P035 Quantifying the mutation burden of a therapeutic course of narrowband ultraviolet B (UVB) to help inform on the carcinogenicity of narrowband UVB

Aminoleveulinate Photodynamic Therapy (ALA-PDT) for Bowen's Disease in a SLE Patient: Case Report and Literature Review.

PD06 (P035) Quantifying the mutation burden of a therapeutic course of narrowband ultraviolet B (UVB) to help inform on the carcinogenicity of narrowband UVB

A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy

Successful Treatment of Bowen's Disease in the Nipple-areola Complex with a Combination of Photodynamic Therapy and Cryotherapy–A Case Report

Role Of Vegf Receptors In Normal And Psoriatic Human Keratinocytes: Evidence From Irradiation With Different Uv Sources

Efficacy of interventions for cutaneous squamous cell carcinoma in situ (Bowen's disease): A systematic review and meta‐analysis of proportions

Successful treatment of giant Bowen's disease with photodynamic therapy and subsequent imiquimod in a case with chronic arsenic exposure

Prognostic Factors for Treatment Failure of Photodynamic Therapy and 5-Fluorouracil in Bowen's Disease

Narrow band ultraviolet monotherapy for severe psoriasis